FROZEN EMBRYO TRANSFER OUTCOMES IN WOMEN WITH PRIOR CESAREAN SECTION AT THE NATIONAL ASSISTED REPRODUCTIVE TECHNOLOGY CENTER
Main Article Content
Abstract
Objective: To evaluate the pregnancy rate and pregnancy outcomes up to 12 weeks after frozen embryo transfer (FET) in women with previous cesarean section. Methods: A retrospective cross-sectional descriptive study of 115 FET cycles at the National Assisted Reproductive Technology Center from January 2023 to December 2024. Cesarean scars were classified based on the 2019 Delphi consensus. Results: The average pregnancy rate was 33.0%, with a cumulative rate of 48.7% after three FET cycles. The group with cesarean scar defect (CSD) and intrauterine fluid had the highest pregnancy rate (37.9%), followed by the group with cesarean section scar without defect (35.1%), and the lowest rate was observed in the CSD without intrauterine fluid group (24.1%) (p = 0.482). Other outcomes, including clinical pregnancy, miscarriage, and ongoing pregnancy beyond 12 weeks, showed no significant differences among the groups. Logistic regression analysis indicated a trend toward increased adverse outcomes in the group with intrauterine fluid, although this was not statistically significant. Conclusion: When residual intrauterine fluid is adequately managed, cesarean section scars do not significantly affect frozen embryo transfer outcomes. This finding supports the importance of scar assessment and individualized treatment planning in counseling patients with a history of cesarean delivery.
Article Details
Keywords
frozen embryo transfer, cesarean section scar, cesarean scar defect, intrauterine fluid, assisted reproductive technology, infertility
References
2. van den Tweel MM, van der Struijs S, Le Cessie S, Boers KE. The impact of caesarean scar niche on fertility - a systematic review. J Obstet Gynaecol J Inst Obstet Gynaecol. 2024;44(1): 2349714. doi:10.1080/01443615. 2024.2349714
3. Gan RX, Li Y, Song J, et al. Pregnancy Outcomes of Different Endometrial Preparation in Patients With a History of Cesarean Section. Front Endocrinol.2022;13.doi:10.3389/ fendo.2022. 813791
4. Mounce G, McVeigh E, Turner K, Child TJ. Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization. Fertil Steril. 2015;104(4): 915-920.e1. doi:10.1016/ j.fertnstert.2015.07.1131
5. Li X, Gao Y, Shi J, Shi W, Bai H. Natural cycle increases the live-birth rate compared with hormone replacement treatment for frozen-thawed single euploid blastocyst transfer. Front Endocrinol. 2022;13. doi:10.3389/fendo.2022. 969379
6. Smith ADAC, Tilling K, Nelson SM, Lawlor DA. Live-birth rate associated with repeat in vitro fertilisation treatment cycles. JAMA. 2015; 314(24): 2654-2662. doi:10.1001/jama.2015. 17296
7. Patounakis G, Ozcan MC, Chason RJ, et al. Impact of a prior cesarean delivery on embryo transfer: a prospective study. Fertil Steril. 2016;106(2): 311-316. doi:10.1016/j.fertnstert. 2016.03.045
8. Wang L, Wang J, Lu N, Liu J, Diao F. Pregnancy and Perinatal Outcomes of Patients With Prior Cesarean Section After a Single Embryo Transfer in IVF/ICSI: A Retrospective Cohort Study. Front Endocrinol. 2022;13:851213. doi:10. 3389/fendo.2022.851213